| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6113645 | Critical Reviews in Oncology/Hematology | 2014 | 10 Pages |
Abstract
The use of VEGFR-TKIs dose not significantly increase the risk of GI perforation in comparison with the controls. Further studies are recommended to investigate this association and the risk differences among different tumor types, VEGFR-TKIs or treatment regimens.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Wei-Xiang Qi, Yuan-Jue Sun, Li-Na Tang, Zan Shen, Yang Yao,